Skip to main content
logo
Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
3.400
-0.170 (-4.76%)
At close: Jul 28, 2026, 4:00 PM EDT
3.350
-0.050 (-1.47%)
After-hours: Jul 28, 2026, 7:03 PM EDT

Eledon Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-78.15-45.62-36.18-116.54-87.97-34.51
Stock-Based Compensation
9.7910.4513.126.558.157.9
Other Adjustments
-5.57-34.83-32.9275.3849.02-2.16
Changes in Accounts Payable
4.836.727.75-2.62.082.14
Changes in Other Operating Activities
0.20.930.96-2.320.29-2.3
Operating Cash Flow
-68.89-62.34-47.27-39.53-28.42-28.91
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Purchases of Investments
-172.4-161.13-156.13-78.29--
Proceeds from Sale of Investments
185.26171.9385.8233--
Investing Cash Flow
12.8610.79-70.31-45.29--

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
0.1253.81133.5233.02-0
Net Common Stock Issued (Repurchased)
0.1253.81133.5233.02-0
Other Financing Activities
------0.45
Financing Cash Flow
53.6953.81133.5233.02--0.45

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-2.342.2615.94-51.8-28.42-29.36

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-68.89-62.34-47.27-39.53-28.42-28.91
Free Cash Flow Growth
------
Free Cash Flow Per Share
-0.76-0.76-0.97-1.61-1.99-1.95
Levered Free Cash Flow
-73.12-37.97-27.47-121.45-85.6-39.37
Unlevered Free Cash Flow
-59.95-75.54-61.02-47.92-86.06-39.37
SEC Filings: 10-K · 10-Q